Wade's Army Report issue

Foundation Phase 1

Organization Overview

First Clinical Trial
2018
NCT03209869
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Wade's Army

Active Ingredients

Drugs in Phase 1 Trials (2)

emd 273063 (1 trial)

haploidentical natural killer cell (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neuroblastoma (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 2